Nippon India Pharma Fund - Direct (G) vs Quant ELSS Tax Saver Fund - Direct (G)

Nippon India Pharma Fund - Direct (G) vs Quant ELSS Tax Saver Fund - Direct (G)

stock1

Nippon India Pharma Fund - Direct (G)

18.23%

stock2

Quant ELSS Tax Saver Fund - Direct (G)

-5.45%

Graph not available
Graph not available

About Fund

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

HDFC Bank Limited

In House Registrar

Very High Risk

5000

8080.97

1.12

554.7449

January 1, 2013

1

Very High Risk

500

10404.84

0.81

388.0504

January 1, 2013

0

23.47 %

20.59 %

18.23 %

36.87 %

15.28 %

-5.45 %

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Archit Singhal

B.COM., MBA., CFA.,

He worked as Research Associate in Institutional Equities with Prabhudas Lilladher and as Research Analyst with Globe Capital Market Ltd.

Sandeep Tandon

MBA

Sandeep Tandon is the founder of the quant group and has 20 years of experience in the financial services industry. Sandeep's previous stints include a key role in setting up the equity derivatives desk at ICICI Securities as vice president. He started his career with the Economic Times Research Bureau, a research wing of the leading financial daily of India, The Economic Times. He later joined IDBI Asset Management (now Principal Asset Management), and was part of the core team that initialized asset management, playing a key role in devising, conceptualizing and marketing one of India's most successful mutual schemes: IDBI I-NITS 95.

Sanjay Arora

ACA,Grad CWA

He has more than 18 years of experience in equity market. Tenure for scheme managment Since 25.07.2013.

Sanjeev Sharma

PGDBA(Fin.), M.com and CerTM (Treasury & Forex Risk)

He has total work experience of 18 years including 13 years of experience in the financial market. He specializes in identifying crucial inflexion points in securities.

Vasav Sahgal

B. com & CFA

He has more than four and a half years of experience handling various front office responsibilities such Equity and Fixed Income research, Portfolio Management, Data Analytics and Python Programming.

Get your FAQs right

When comparing Nippon India Pharma Fund - Direct (G) vs Quant ELSS Tax Saver Fund - Direct (G), consider factors such as historical performance, expense ratios, investment strategy, risk level, and the fund manager's credibility. Moreover, look at asset allocation and how each fund fits your investment goals.
Yes, you can invest in both Nippon India Pharma Fund - Direct (G) and Quant ELSS Tax Saver Fund - Direct (G) at the same time. This can help diversify your portfolio and balance risk, provided the fund manager's investment strategies streamline each other.
While comparing Nippon India Pharma Fund - Direct (G) and Quant ELSS Tax Saver Fund - Direct (G), the portfolio turnover ratio indicates how frequently assets within the fund are bought and sold. A high turnover may lead to higher transaction costs and tax implications, while a low turnover ratio indicates a buy-and-hold strategy.
Yes, you can typically switch between Nippon India Pharma Fund - Direct (G) and Quant ELSS Tax Saver Fund - Direct (G), subject to the fund's policies and any applicable fees. It is important to consider potential tax implications and the timing of your switch.
Yes, you can compare Nippon India Pharma Fund - Direct (G) and Quant ELSS Tax Saver Fund - Direct (G) based on their dividend payouts. Look at dividends profit, consistency, and growth, as these factors can influence your overall return on investment.

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions